Literature DB >> 21615376

Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies.

Ersi Voskaridou, Dimitrios Christoulas, Evangelos Terpos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21615376     DOI： 10.1111/j.1365-2141.2011.08626.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

1.  Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine.

Authors:  Robert W Grady; Renzo Galanello; Rachel E Randolph; Dorothy A Kleinert; Carlo Dessi; Patricia J Giardina
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 2.  How we manage iron overload in sickle cell patients.

Authors:  Thomas D Coates; John C Wood
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

3.  Iron overload in transfusion-dependent patients.

Authors:  Thomas D Coates
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.

Authors:  D J Pennell; J P Carpenter; M Roughton; Zi Cabantchik
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-12       Impact factor: 5.364

Review 5.  Iron overload in the HCT patient: a review.

Authors:  Pavan Tenneti; Aleksander Chojecki; Mary Ann Knovich
Journal:  Bone Marrow Transplant       Date:  2021-03-29       Impact factor: 5.174

Review 6.  Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.

Authors:  Antoine N Saliba; Afif R Harb; Ali T Taher
Journal:  J Blood Med       Date:  2015-06-17

7.  Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major.

Authors:  Hossein Karami; Mehrnoush Kosaryan; Arash Hadian Amree; Hadi Darvishi-Khezri; Masoomeh Mousavi
Journal:  Clin Pract       Date:  2017-01-12

Review 8.  Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series.

Authors:  Valeria Maria Pinto; Gian Luca Forni
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

9.  Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload.

Authors:  Samin Alavi; Elham Sadeghi; Azin Ashenagar
Journal:  Blood Res       Date:  2014-03-24

10.  Chelation of Thallium (III) in Rats Using Combined Deferasirox and Deferiprone Therapy.

Authors:  Samie Salehi; Amir Sh Saljooghi; Somayeh Badiee; Mojtaba Mashmool Moqadam
Journal:  Toxicol Res       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.